2022 Revenues ($USD) : $7,298,798,252
2022 Revenues (foreign currencies) : JP¥801,700,000,000
2022 R&D spend : $412,418,063
2022 Number of Employees : n/a
Fiscal Year End : 3/31/2022
Company CEO : Teiichi Goto, president and CEO

Fujifilm Healthcare Americas is headquartered in Lexington, Massachusetts. It offers diagnostic and enterprise imaging products and services across prevention, diagnosis and treatment. The medical imaging portfolio includes solutions for digital radiography, mammography, computed tomography, magnetic resonance imaging, ultrasound, endoscopy and endosurgery. Fujifilm’s Synapse Enterprise Imaging portfolio provides healthcare professionals with imaging and data access to deliver a complete patient record. Fujifilm’s artificial intelligence initiative, REiLI, combines the Tokyo-based parent company’s image-processing expertise with cutting-edge AI innovations. The In-Vitro Diagnostic portfolio provides molecular-based immunoassay technology for liver surveillance, clinical diagnostic chemicals for leading laboratories across the country, and diagnostic chemicals for OEM white labeling products. In 2022, the company won a $405 million Defense Department contract for endoscopy tech and training. The company also launched its FDR Cross hybrid c-arm and portable X-ray system in the U.S., calling it the world’s first two-in-one fluoroscopy and digital radiography system.  –JH